Ondansetron Eg

Ondansetron, the active ingredient in Ondansetron Eg, is a 5-HT3 receptor antagonist presented as a 4 mg oral tablet for systemic use. It helps prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery in adult and pediatric patients. GNH USA supplies Ondansetron Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron is a selective serotonin 5‑HT3 receptor antagonist used to manage nausea and vomiting in several clinical settings. - Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: helps control symptoms during and after radiotherapy. - Post‑operative nausea and vomiting: decreases the incidence of nausea and vomiting after surgical procedures. - Pregnancy‑associated nausea (hyperemesis gravidarum): used when other treatments are ineffective, under specialist supervision.

Side effects are generally mild to moderate and vary with the route of administration.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: occasional bowel movement difficulty. - Diarrhoea: loose stools, usually transient. - Fatigue: feeling of tiredness or reduced energy. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Cardiac arrhythmia: QT‑interval prolongation, especially with IV use. - Severe hypersensitivity: rash, itching, swelling, or anaphylaxis. - Serotonin syndrome: agitation, hyperreflexia, tremor when combined with serotonergic agents. - Hepatic dysfunction: elevated liver enzymes in rare cases. - Vision changes: blurred vision or visual disturbances.

When prescribing Ondansetron, clinicians should consider several safety aspects. - Cardiac monitoring: assess baseline ECG in patients with known cardiac disease or electrolyte imbalance. - Electrolyte balance: correct hypokalaemia, hypomagnesemia, or hypocalcaemia before use. - Drug interactions: review concomitant medications that may affect QT interval. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly indicated. - Storage: Store below 25°C: keep in the original pack, protect from moisture.

Ondansetron may interact with several other medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Apatinol (   )      ...  ....  ....  ....  ...  ...  ...  ...  …  …  ....  … …  ....  …  ...  ... …  ...  ");

Moderate  ");

"  " """"" "" "" """" "" " """ "" """ "" "" "" "" "" """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""